MA28863B1 - AMIDES DES ACIDES 5- ET 6-AMINOALKYLE INDOLE -2- CARBOXYLIQUES 3-SUBSTITUES ET COMPOSES ANALOGUES ASSOCIES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE l Epsilon - Google Patents

AMIDES DES ACIDES 5- ET 6-AMINOALKYLE INDOLE -2- CARBOXYLIQUES 3-SUBSTITUES ET COMPOSES ANALOGUES ASSOCIES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE l Epsilon

Info

Publication number
MA28863B1
MA28863B1 MA29757A MA29757A MA28863B1 MA 28863 B1 MA28863 B1 MA 28863B1 MA 29757 A MA29757 A MA 29757A MA 29757 A MA29757 A MA 29757A MA 28863 B1 MA28863 B1 MA 28863B1
Authority
MA
Morocco
Prior art keywords
epsilon
substituted
carboxylic acid
acid amides
kinase inhibitors
Prior art date
Application number
MA29757A
Other languages
English (en)
Inventor
William Arthur Metz Jr
Fa-Xiang Ding
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MA28863B1 publication Critical patent/MA28863B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA29757A 2004-08-19 2007-03-14 AMIDES DES ACIDES 5- ET 6-AMINOALKYLE INDOLE -2- CARBOXYLIQUES 3-SUBSTITUES ET COMPOSES ANALOGUES ASSOCIES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE l Epsilon MA28863B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60338004P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
MA28863B1 true MA28863B1 (fr) 2007-09-03

Family

ID=35311279

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29757A MA28863B1 (fr) 2004-08-19 2007-03-14 AMIDES DES ACIDES 5- ET 6-AMINOALKYLE INDOLE -2- CARBOXYLIQUES 3-SUBSTITUES ET COMPOSES ANALOGUES ASSOCIES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE l Epsilon

Country Status (27)

Country Link
US (2) US7629376B2 (fr)
EP (1) EP1794122B1 (fr)
JP (1) JP4843608B2 (fr)
KR (2) KR20130038409A (fr)
CN (1) CN101006055B (fr)
AR (1) AR050919A1 (fr)
AT (1) ATE508112T1 (fr)
AU (1) AU2005277523B2 (fr)
BR (1) BRPI0514380A (fr)
CA (1) CA2577667C (fr)
DE (1) DE602005027858D1 (fr)
GT (1) GT200500214A (fr)
HK (1) HK1105196A1 (fr)
IL (1) IL181156A (fr)
JO (1) JO2724B1 (fr)
MA (1) MA28863B1 (fr)
MX (1) MX2007001382A (fr)
NO (1) NO20071466L (fr)
NZ (1) NZ552800A (fr)
PA (1) PA8642901A1 (fr)
PE (1) PE20060498A1 (fr)
RU (1) RU2369599C2 (fr)
SV (1) SV2006002192A (fr)
TW (1) TWI357897B (fr)
UY (1) UY29078A1 (fr)
WO (1) WO2006023467A1 (fr)
ZA (1) ZA200700651B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018238B2 (en) 2009-02-12 2015-04-28 Pharmadesign, Inc. Inhibitor of casein kinase 1δ and casein kinase 1ε
CN102481289A (zh) * 2009-04-17 2012-05-30 赛林药物股份有限公司 治疗与蛋白激酶ck2活性有关的疾病的方法
MX350418B (es) 2012-06-27 2017-09-06 4Sc Discovery Gmbh Inhibidores de bifluorodioxalano-amino-bencimidazol quinasa para el tratamiento de cáncer, inflamación autoinmune y trastornos del sistema nervioso central.
CN111757879A (zh) 2018-01-29 2020-10-09 卡地拉健康护理有限公司 用作抗菌剂的杂环化合物
WO2022006377A2 (fr) * 2020-07-02 2022-01-06 Mbq Pharma Inhibiteurs hétérocycliques de gtpases rho pour le traitement d'une maladie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296471A (en) 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
CA2494962C (fr) * 2002-08-09 2011-06-14 Merck & Co., Inc. Inhibiteurs de tyrosine kinases
ATE428711T1 (de) * 2003-12-11 2009-05-15 Aventis Pharma Inc Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3- cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon

Also Published As

Publication number Publication date
ATE508112T1 (de) 2011-05-15
CN101006055A (zh) 2007-07-25
BRPI0514380A (pt) 2008-06-10
RU2007109783A (ru) 2008-09-27
CN101006055B (zh) 2011-06-22
US20090082340A1 (en) 2009-03-26
JO2724B1 (en) 2013-09-15
CA2577667A1 (fr) 2006-03-02
IL181156A (en) 2011-09-27
RU2369599C2 (ru) 2009-10-10
SV2006002192A (es) 2006-06-28
JP4843608B2 (ja) 2011-12-21
IL181156A0 (en) 2007-07-04
WO2006023467A1 (fr) 2006-03-02
NZ552800A (en) 2010-11-26
HK1105196A1 (en) 2008-02-06
UY29078A1 (es) 2006-03-31
JP2008510017A (ja) 2008-04-03
TWI357897B (en) 2012-02-11
US7629376B2 (en) 2009-12-08
EP1794122B1 (fr) 2011-05-04
CA2577667C (fr) 2011-01-04
PA8642901A1 (es) 2006-05-16
AU2005277523A1 (en) 2006-03-02
EP1794122A1 (fr) 2007-06-13
US20080027124A1 (en) 2008-01-31
MX2007001382A (es) 2007-04-19
NO20071466L (no) 2007-04-19
US7923466B2 (en) 2011-04-12
GT200500214A (es) 2006-03-27
ZA200700651B (en) 2008-09-25
PE20060498A1 (es) 2006-07-10
DE602005027858D1 (de) 2011-06-16
AU2005277523B2 (en) 2011-09-29
KR20130038409A (ko) 2013-04-17
TW200621711A (en) 2006-07-01
AR050919A1 (es) 2006-12-06
KR20070043012A (ko) 2007-04-24

Similar Documents

Publication Publication Date Title
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
MA29119B1 (fr) Derives de pyrrolidyle de composes heteroaromatiques servant d'inhibiteurs de phosphodiesterases
HK1093688A1 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
HK1105198A1 (en) Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
IL157418A0 (en) 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
IL184499A0 (en) Pyrazole derivatives for the inhibition of cdk's and gsk's
AU2003302626A1 (en) 1, 2, 5-thiadiazolidin-3-one 1, 1 dioxide derivatives as inhibitors of protein tyrosine phosphatase ptp1b
IL166431A0 (en) Microcapsules with modified release of active principles with low solubility for oral delivery
MA28863B1 (fr) AMIDES DES ACIDES 5- ET 6-AMINOALKYLE INDOLE -2- CARBOXYLIQUES 3-SUBSTITUES ET COMPOSES ANALOGUES ASSOCIES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE l Epsilon
HUP0500111A3 (en) Indolinone derivatives useful as protein kinase inhibitors
IL172167A0 (en) Pharmaceutically useful salts of carboxylic acid derivatives
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
MA30563B1 (fr) Sels de n-hydroxy-3-[4-[[[2-(2-méthyl-1h-indol-3-yl)éthyl]amino]méthyl]phényl]-2e-2-propénamide
EG26235A (en) Benzylpiprazine derivatives have anti-GPR38 receptor activity
AU2003250935A8 (en) Bile acid derivatives as agonists of the farnesoid x receptor
TNSN05222A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
ZA200705614B (en) Pyrazole derivatives for the inhibition of CDK's and GSK's
WO2006114666A8 (fr) Derives d'aryl-1,4-pyrazine
ITBO20050705A1 (it) Macchina per la fabbricazione e l'erogazione di frappe' di gelato o schake
EE04869B1 (et) Alfa-lipohape v?i selle derivaadid kasutamiseks migreeni ravis
EP1620088A4 (fr) Derives d'acide indole acetique et leur utilisation en tant qu'agents pharmaceutiques
MY145122A (en) Phenylacetic acid derivatives as cox-2 inhibitors
MX2009002538A (es) Derivados de 4-oxo-2,3,4,5-tetrahidro-benzo[b][1,4]diazepina.
IL172377A0 (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders